ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 48 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $46,734,228 | +11.4% | 4,081,592 | 0.0% | 0.99% | +30.7% |
Q2 2023 | $41,958,766 | +33.2% | 4,081,592 | 0.0% | 0.76% | +22.8% |
Q1 2023 | $31,509,890 | +5.0% | 4,081,592 | 0.0% | 0.62% | +7.8% |
Q4 2022 | $29,999,701 | +2.1% | 4,081,592 | 0.0% | 0.57% | +5.1% |
Q3 2022 | $29,387,000 | -15.4% | 4,081,592 | 0.0% | 0.55% | -13.2% |
Q2 2022 | $34,734,000 | -5.1% | 4,081,592 | 0.0% | 0.63% | +5.9% |
Q1 2022 | $36,612,000 | -35.2% | 4,081,592 | 0.0% | 0.59% | -18.3% |
Q4 2021 | $56,530,000 | +29.8% | 4,081,592 | 0.0% | 0.73% | +51.8% |
Q3 2021 | $43,551,000 | +57.6% | 4,081,592 | +32.9% | 0.48% | +71.1% |
Q2 2021 | $27,639,000 | -15.1% | 3,070,955 | 0.0% | 0.28% | -7.9% |
Q1 2021 | $32,552,000 | -15.9% | 3,070,955 | 0.0% | 0.30% | -10.3% |
Q4 2020 | $38,694,000 | +19.9% | 3,070,955 | -16.3% | 0.34% | -16.5% |
Q3 2020 | $32,268,000 | -9.5% | 3,670,955 | 0.0% | 0.41% | -19.1% |
Q2 2020 | $35,645,000 | +237.2% | 3,670,955 | 0.0% | 0.50% | +182.0% |
Q1 2020 | $10,572,000 | -25.0% | 3,670,955 | 0.0% | 0.18% | -11.4% |
Q4 2019 | $14,096,000 | -3.0% | 3,670,955 | 0.0% | 0.20% | -27.2% |
Q3 2019 | $14,537,000 | -5.9% | 3,670,955 | 0.0% | 0.28% | +15.5% |
Q2 2019 | $15,455,000 | -38.6% | 3,670,955 | 0.0% | 0.24% | -38.7% |
Q1 2019 | $25,183,000 | +107.5% | 3,670,955 | +11.3% | 0.39% | +74.1% |
Q4 2018 | $12,139,000 | -41.9% | 3,298,516 | 0.0% | 0.22% | -10.8% |
Q3 2018 | $20,880,000 | -16.4% | 3,298,516 | 0.0% | 0.25% | -15.8% |
Q2 2018 | $24,970,000 | -5.4% | 3,298,516 | 0.0% | 0.30% | -8.9% |
Q1 2018 | $26,388,000 | -28.6% | 3,298,516 | 0.0% | 0.33% | -30.0% |
Q4 2017 | $36,943,000 | -3.4% | 3,298,516 | 0.0% | 0.47% | +27.6% |
Q3 2017 | $38,263,000 | – | 3,298,516 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76,809,898 | 25.63% |
Lynx1 Capital Management LP | 2,404,614 | $27,532,830 | 18.21% |
GREAT POINT PARTNERS LLC | 3,078,633 | $35,250,348 | 6.42% |
Ghost Tree Capital, LLC | 664,132 | $7,604,311 | 2.50% |
Frazier Life Sciences Management, L.P. | 2,985,757 | $34,186,918 | 2.27% |
Paradigm Biocapital Advisors LP | 2,421,743 | $27,728,957 | 1.88% |
COMMODORE CAPITAL LP | 1,325,000 | $15,171,250 | 1.77% |
Nan Fung Group Holdings Ltd | 182,280 | $2,087,106 | 1.69% |
Omega Fund Management, LLC | 153,700 | $1,759,865 | 1.62% |
Octagon Capital Advisors LP | 750,000 | $8,587,500 | 1.32% |